TIGEN Trademark

Trademark Overview


On Thursday, February 4, 2021, a trademark application was filed for TIGEN with the United States Patent and Trademark Office. The USPTO has given the TIGEN trademark a serial number of 79311144. The federal status of this trademark filing is OPPOSITION PENDING as of Monday, March 28, 2022. This trademark is owned by Tigen Pharma SA. The TIGEN trademark is filed in the Chemical Products, Pharmaceutical Products, Medical Instrument Products, Computer & Software Services & Scientific Services, and Medical & Beauty Services & Agricultural Services categories with the following description:

Pharmaceutical products and medical preparations, namely, gene-modified and non-gene-modified cellular therapies for the treatment of localized and systemic malignant hematological and oncological diseases, genetic diseases, autoimmune diseases and infectious diseases

Chemical, biochemical, biological and biotechnological preparations, namely, polypeptides and proteins, for use in industry and science; chemical, biochemical, biological and biotechnological preparations, namely, polypeptides and proteins, for use in the development being the manufacture, and manufacture of reagents for industrial or scientific use; chemical, biochemical, biological and biotechnological preparations, namely, polypeptides or proteins, for use of laboratories, diagnostics and analyses for industrial or scientific use; chemical, biochemical, biological and biotechnological substances, namely, polypeptides and proteins, for use in the manufacture of pharmaceuticals

Medical services; pharmacy advice services, namely, pharmaceutical consultation; medical clinic services provided by medical laboratories for diagnostic purposes; preparation and dispensing of medication; preparation of prescriptions by pharmacists

Medical instruments, equipment and apparatus, namely, instruments, equipment and apparatus for cell and cell material collection, thawing, washing, selection, expansion, modification, harvesting, final formulation, freezing, storage and infusion into a patient in the fields of genetic diseases, autoimmune diseases, infectious diseases, localized and systemic malignant hematological and oncological diseases and other cell and cell-material based diseases and conditions

Scientific research, technological development of new products for third parties; medical research; scientific and industrial research in biotechnology, biology, diseases, genetic diseases, autoimmune diseases, infectious and tumor diseases and the treatment of diseases, genetic diseases, autoimmune diseases, infectious and tumor diseases; research in the field of biomedical and phytopharmaceutical technology; scientific laboratory services; pharmaceutical research and development services; scientific services, namely, development of medicines, active substances and vaccines; scientific services, namely, development of food supplement; design and development of computer hardware and software for use in medical and scientific research and in the development of new products, in research and development of new products in the field of biotechnology, biology, diseases, genetic diseases, autoimmune diseases, infectious diseases and tumor diseases and the treatment of diseases, genetic disea...
tigen

General Information


Serial Number79311144
Word MarkTIGEN
Filing DateThursday, February 4, 2021
Status774 - OPPOSITION PENDING
Status DateMonday, March 28, 2022
Registration Number0000000
Registration DateNOT AVAILABLE
Mark Drawing5000 - Drawing with word(s) / letter(s) / number(s) in Stylized form
Published for Opposition DateTuesday, February 15, 2022

Trademark Statements


Goods and ServicesPharmaceutical products and medical preparations, namely, gene-modified and non-gene-modified cellular therapies for the treatment of localized and systemic malignant hematological and oncological diseases, genetic diseases, autoimmune diseases and infectious diseases
Goods and ServicesChemical, biochemical, biological and biotechnological preparations, namely, polypeptides and proteins, for use in industry and science; chemical, biochemical, biological and biotechnological preparations, namely, polypeptides and proteins, for use in the development being the manufacture, and manufacture of reagents for industrial or scientific use; chemical, biochemical, biological and biotechnological preparations, namely, polypeptides or proteins, for use of laboratories, diagnostics and analyses for industrial or scientific use; chemical, biochemical, biological and biotechnological substances, namely, polypeptides and proteins, for use in the manufacture of pharmaceuticals
Goods and ServicesMedical services; pharmacy advice services, namely, pharmaceutical consultation; medical clinic services provided by medical laboratories for diagnostic purposes; preparation and dispensing of medication; preparation of prescriptions by pharmacists
Goods and ServicesMedical instruments, equipment and apparatus, namely, instruments, equipment and apparatus for cell and cell material collection, thawing, washing, selection, expansion, modification, harvesting, final formulation, freezing, storage and infusion into a patient in the fields of genetic diseases, autoimmune diseases, infectious diseases, localized and systemic malignant hematological and oncological diseases and other cell and cell-material based diseases and conditions
Goods and ServicesScientific research, technological development of new products for third parties; medical research; scientific and industrial research in biotechnology, biology, diseases, genetic diseases, autoimmune diseases, infectious and tumor diseases and the treatment of diseases, genetic diseases, autoimmune diseases, infectious and tumor diseases; research in the field of biomedical and phytopharmaceutical technology; scientific laboratory services; pharmaceutical research and development services; scientific services, namely, development of medicines, active substances and vaccines; scientific services, namely, development of food supplement; design and development of computer hardware and software for use in medical and scientific research and in the development of new products, in research and development of new products in the field of biotechnology, biology, diseases, genetic diseases, autoimmune diseases, infectious diseases and tumor diseases and the treatment of diseases, genetic diseases, autoimmune diseases, infectious diseases and tumor diseases; upgrading, maintenance and rental of computer software; updating, maintenance and rental of computer software for use in medical and scientific research and in the development of new products, in research and development of new products in the field of biotechnology, biology, diseases, genetic diseases, autoimmune diseases, infectious diseases and tumor diseases and the treatment of diseases, genetic diseases, autoimmune diseases, infectious diseases and tumor diseases; software as a service (SaaS) services featuring software for controlling end-to-end process development, manufacturing, quality, and supply chain steps and featuring artificial intelligence search engine software to be used in medical and scientific research and in the development of new products in research and development of new products in the field of biotechnology, biology, diseases, genetic diseases, autoimmune diseases, infectious diseases and tumor diseases and the treatment of diseases, genetic diseases, autoimmune diseases, infectious diseases and tumor diseases; chemical and biological laboratory services

Classification Information


International Class001 - Chemicals used in industry, science and photography, as well as in agriculture, horticulture and forestry; unprocessed artificial resins; unprocessed plastics; manures; fire extinguishing compositions; tempering and soldering preparations; chemical substances for preserving foodstuffs; tanning substances; adhesives used in industry.
US Class Codes001, 005, 006, 010, 026, 046
Class Status Code6 - Active
Class Status DateMonday, January 10, 2022
Primary Code001
First Use Anywhere DateNOT AVAILABLE
First Use In Commerce DateNOT AVAILABLE

International Class005 - Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes; dietetic substances adapted for medical use, food for babies; plasters, materials for dressings; material for stopping teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides.
US Class Codes006, 018, 044, 046, 051, 052
Class Status Code6 - Active
Class Status DateMonday, January 10, 2022
Primary Code005
First Use Anywhere DateNOT AVAILABLE
First Use In Commerce DateNOT AVAILABLE

International Class010 - Surgical, medical, dental, and veterinary apparatus and instruments, artificial limbs, eyes, and teeth; orthopedic articles; suture materials.
US Class Codes026, 039, 044
Class Status Code6 - Active
Class Status DateMonday, January 10, 2022
Primary Code010
First Use Anywhere DateNOT AVAILABLE
First Use In Commerce DateNOT AVAILABLE

International Class042 - Scientific and technological services and research and design relating thereto; industrial analysis and research services; design and development of computer hardware and software.
US Class Codes100, 101
Class Status Code6 - Active
Class Status DateMonday, January 10, 2022
Primary Code042
First Use Anywhere DateNOT AVAILABLE
First Use In Commerce DateNOT AVAILABLE

International Class044 - Medical services; veterinary services; hygienic and beauty care for human beings or animals; agriculture, horticulture and forestry services.
US Class Codes100, 101
Class Status Code6 - Active
Class Status DateMonday, January 10, 2022
Primary Code044
First Use Anywhere DateNOT AVAILABLE
First Use In Commerce DateNOT AVAILABLE

Trademark Owner History


Party NameTigen Pharma SA
Party Type20 - Owner at Publication
Legal Entity Type33 - NOT AVAILABLE
AddressCH

Party NameTigen Pharma SA
Party Type10 - Original Applicant
Legal Entity Type33 - NOT AVAILABLE
AddressCH

Trademark Events


Event DateEvent Description
Sunday, December 31, 2023NEW REPRESENTATIVE AT IB RECEIVED
Monday, December 11, 2023NOTIFICATION OF POSSIBLE OPPOSITION - PROCESSED BY IB
Wednesday, November 8, 2023NOTIFICATION OF POSSIBLE OPPOSITION SENT TO IB
Wednesday, November 8, 2023NOTIFICATION OF POSSIBLE OPPOSITION CREATED, TO BE SENT TO IB
Tuesday, August 2, 2022CORRECTION FROM THE IB EXAMINED, NO ACTION IS NEEDED
Sunday, June 5, 2022CORRECTION TRANSACTION RECEIVED FROM IB
Sunday, April 10, 2022REFUSAL PROCESSED BY IB
Monday, March 28, 2022OPPOSITION INSTITUTED NO. 999999
Wednesday, March 16, 2022OPPOSITION NOTICE (IB REFUSAL) SENT TO IB
Wednesday, March 16, 2022OPPOSITION NOTICE (IB REFUSAL) CREATED
Tuesday, March 15, 2022OPPOSITION PAPERS RECEIVED AT TTAB
Tuesday, February 15, 2022OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Tuesday, February 15, 2022PUBLISHED FOR OPPOSITION
Monday, February 14, 2022NOTIFICATION PROCESSED BY IB
Wednesday, January 26, 2022NOTIFICATION OF POSSIBLE OPPOSITION SENT TO IB
Wednesday, January 26, 2022NOTICE OF START OF OPPOSITION PERIOD CREATED, TO BE SENT TO IB
Wednesday, January 26, 2022NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Tuesday, January 11, 2022LAW OFFICE PUBLICATION REVIEW COMPLETED
Tuesday, January 11, 2022ASSIGNED TO LIE
Monday, January 10, 2022APPROVED FOR PUB - PRINCIPAL REGISTER
Monday, January 10, 2022EXAMINER'S AMENDMENT ENTERED
Monday, January 10, 2022NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED
Monday, January 10, 2022EXAMINERS AMENDMENT E-MAILED
Monday, January 10, 2022EXAMINERS AMENDMENT -WRITTEN
Friday, January 7, 2022APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED
Friday, January 7, 2022TEAS CHANGE OF CORRESPONDENCE RECEIVED
Friday, January 7, 2022TEAS CHANGE OF DOMESTIC REPRESENTATIVES ADDRESS
Friday, January 7, 2022ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
Friday, January 7, 2022TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
Friday, January 7, 2022TEAS CHANGE OF OWNER ADDRESS RECEIVED
Monday, October 4, 2021REFUSAL PROCESSED BY IB
Tuesday, September 14, 2021NON-FINAL ACTION MAILED - REFUSAL SENT TO IB
Tuesday, September 14, 2021REFUSAL PROCESSED BY MPU
Tuesday, September 14, 2021NON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW
Monday, September 13, 2021NON-FINAL ACTION WRITTEN
Friday, August 27, 2021ASSIGNED TO EXAMINER
Friday, August 20, 2021NEW REPRESENTATIVE AT IB RECEIVED
Tuesday, May 25, 2021APPLICATION FILING RECEIPT MAILED
Friday, May 21, 2021NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Thursday, May 20, 2021SN ASSIGNED FOR SECT 66A APPL FROM IB